Akiko Koga

Title: Akiko Koga: Innovator in Antibody Engineering

Introduction

Akiko Koga is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of antibody engineering, particularly in the development of structural isomers of sc(Fv)2 compositions. Her work has implications for therapeutic applications in human health.

Latest Patents

Akiko Koga holds a patent for "Structural isomers of sc(Fv)2." This patent details the separation of structural isomers in sc(Fv)2 compositions of anti-human Mpl antibody and humanized anti-human Mpl antibody. The obtained structural isomers were cleaved at their linkers to confirm that they are of single chain diabody type and bivalent scFv type. Furthermore, the agonistic activities of these structural isomers were found to be significantly different. The inventors also discovered that the content ratio of the structural isomers in sc(Fv)2 compositions could be regulated by altering temperature, modifying lengths of the linkers of sc(Fv)2, or amino acids in their variable regions. She has 1 patent to her name.

Career Highlights

Akiko Koga is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her work at Chugai has allowed her to focus on innovative research in the field of biopharmaceuticals.

Collaborations

She has collaborated with notable colleagues such as Tomoyuki Igawa and Hiroyuki Tsunoda, contributing to advancements in their shared field of research.

Conclusion

Akiko Koga's innovative work in antibody engineering and her patent on structural isomers of sc(Fv)2 highlight her significant role in advancing biopharmaceutical research. Her contributions continue to impact the field positively.